Elanco Animal Health Inc
ELAN14.020USD
+0.230+1.67%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
6.96BCap. mercado
18.66P/E TTM
Más Datos de Elanco Animal Health Inc Compañía
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Información de la empresa
Símbolo de cotizaciónELAN
Nombre de la empresaElanco Animal Health Inc
Fecha de salida a bolsaSep 20, 2018
Director ejecutivoMr. Jeffrey N. (Jeff) Simmons
Número de empleados9000
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 20
Dirección2500 Innovation Way N
CiudadGREENFIELD
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal46140-9163
Teléfono18773526261
Sitio Webhttps://www.elanco.com/
Símbolo de cotizaciónELAN
Fecha de salida a bolsaSep 20, 2018
Director ejecutivoMr. Jeffrey N. (Jeff) Simmons
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
150.03K
+26.80%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
99.26K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
80.96K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
79.40K
--
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
74.50K
--
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
62.55K
-1.82%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
53.92K
+100.82%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
150.03K
+26.80%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
99.26K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
80.96K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Pet Health
635.00M
53.23%
Farm Animal
546.00M
45.77%
Contract Manufacturing
12.00M
1.01%
Por regiónUSD
Nombre
Ganancia
Proporción
International
639.00M
53.56%
United States
554.00M
46.44%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pet Health
635.00M
53.23%
Farm Animal
546.00M
45.77%
Contract Manufacturing
12.00M
1.01%
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Dodge & Cox
16.70%
PRIMECAP Management Company
10.11%
The Vanguard Group, Inc.
9.69%
Fidelity Management & Research Company LLC
7.71%
Black Creek Investment Management, Inc.
4.44%
Other
51.35%
Accionistas
Accionistas
Proporción
Dodge & Cox
16.70%
PRIMECAP Management Company
10.11%
The Vanguard Group, Inc.
9.69%
Fidelity Management & Research Company LLC
7.71%
Black Creek Investment Management, Inc.
4.44%
Other
51.35%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
63.16%
Investment Advisor/Hedge Fund
32.92%
Hedge Fund
3.35%
Individual Investor
1.08%
Research Firm
1.01%
Sovereign Wealth Fund
0.79%
Pension Fund
0.77%
Bank and Trust
0.44%
Family Office
0.11%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
879
514.22M
103.54%
-39.32M
2025Q1
974
511.32M
102.96%
-71.50M
2024Q4
996
503.77M
101.85%
-80.73M
2024Q3
1000
494.48M
100.04%
-96.31M
2024Q2
1034
494.94M
100.16%
-92.98M
2024Q1
1051
494.01M
100.22%
-99.13M
2023Q4
1048
492.96M
100.04%
-103.67M
2023Q3
1055
493.54M
100.18%
-93.98M
2023Q2
1067
490.17M
99.54%
-75.35M
2023Q1
1071
498.03M
101.25%
-46.19M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Dodge & Cox
82.92M
16.7%
-260.08K
-0.31%
Mar 31, 2025
PRIMECAP Management Company
50.22M
10.11%
-941.63K
-1.84%
Mar 31, 2025
The Vanguard Group, Inc.
48.14M
9.69%
-437.73K
-0.90%
Mar 31, 2025
Fidelity Management & Research Company LLC
38.30M
7.71%
+9.79M
+34.35%
Mar 31, 2025
Black Creek Investment Management, Inc.
22.04M
4.44%
+1.61M
+7.87%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
20.46M
4.12%
+2.56M
+14.32%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.06M
4.04%
-618.85K
-2.99%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
15.98M
3.22%
+292.65K
+1.87%
Mar 31, 2025
Fidelity Institutional Asset Management
15.55M
3.13%
+3.83M
+32.70%
Mar 31, 2025
Shapiro Capital Management LLC
12.33M
2.48%
-24.38K
-0.20%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
SPDR S&P Pharmaceuticals ETF
3.83%
iShares U.S. Pharmaceuticals ETF
3.57%
First Trust Health Care Alphadex Fund
3.03%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.72%
First Trust NASDAQ Pharmaceuticals ETF
2.36%
Brandes US Small-Mid Cap Value ETF
2.14%
VanEck Agribusiness ETF
1.51%
First Trust Mid Cap Value AlphaDEX Fund
0.98%
Global X Adaptive US Factor ETF
0.72%
Federated Hermes MDT Large Cap Value ETF
0.7%
Ver más
SPDR S&P Pharmaceuticals ETF
Proporción3.83%
iShares U.S. Pharmaceuticals ETF
Proporción3.57%
First Trust Health Care Alphadex Fund
Proporción3.03%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción2.72%
First Trust NASDAQ Pharmaceuticals ETF
Proporción2.36%
Brandes US Small-Mid Cap Value ETF
Proporción2.14%
VanEck Agribusiness ETF
Proporción1.51%
First Trust Mid Cap Value AlphaDEX Fund
Proporción0.98%
Global X Adaptive US Factor ETF
Proporción0.72%
Federated Hermes MDT Large Cap Value ETF
Proporción0.7%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
